The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma

Cancer Research

Volumn 57, Issue 23, 1997, Pages 5386-5390

  Littlewood Evans, Amanda J ^a,f   Bilbe, Graeme ^a   Bowler, Wayne B ^b,d   Farley, David ^a   Wlodarski, Brenda ^b,d   Kokubo, Toshio ^e   Inaoka, Tetsuya ^e   Sloane, John ^c,d   Evans, Dean B ^a   Gallagher, James A ^b,d  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Human Bone Cell Research Group   (United Kingdom)

^c Department of Pathology ^*  (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e Novartis Pharma Ltd   (Japan)

^f FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; PROTEINASE;

AMINO ACID SEQUENCE; ARTICLE; BONE METASTASIS; BREAST CARCINOMA; CANCER INVASION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TARGET CELL;

BLOTTING, SOUTHERN; BONE NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CATHEPSINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; OSTEOCLASTS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 15144356711     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gay, S., Gay, R. E., and Koopman, W. J. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann. Rheum. Dis., 52: S39-S47, 1993.
2. van der Stappen, J. W. J., Paraskeva, C., Williams, A. C., Hague, A., and Maciewicz, R. A. Relationship between the secretion of cysteine proteinases and their inhibitors and malignant potential. Biochem. Soc. Trans., 19: 362S, 1991.
3. Tezuka, K., Tezuka, Y., Maejima, A., Sato, T., Nemoto, K., Kamioka, H., Hakeda, Y., and Kumegawa, M. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J. Biol. Chem., 269: 1106-1109, 1994.
4. Inaoka, T., Bilbe, G., Ishibashi, O., Tezuka, K., Kumegawa, M., and Kokubo, T. Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. Bioehem. Biophys. Res. Commun., 206: 89-96, 1995.
5. Littlewood-Evans, A., Kokubo, T., Ishibashi, O., Inaoka, B., Wlodarski, B., Gallagher, J. A., and Bilbe, G. Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone, 20: 81-86, 1997.
6. Bartek, J., Bartkova, J., Kyprianou, N., Lalani, E. N., Staskova, Z., Shearer, M., Chang, S., and Taylor-Papadimitriou, J. Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc. Natl. Acad. Sci. USA, 88: 3520-3524, 1991.
7. Elston, C. W., and Ellis, I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathology, 19: 403-410, 1991.
8. Inui, T., Ishibashi, O., Inaoka, T., Origane, Y., Kumegawa, M., Kokubo, T., and Yamamura, T. Cathepsin K antisense oligonucleotide inhibits osteoclastic bone resorption. J. Biol. Chem., 272: 8109-8112, 1997.
9. Komminoth, P. Digoxigenin as an alternative probe labelling for in situ hybridization. Diagn. Mol. Pathol., 1: 142-150, 1992.
10. Drake, F. H., Dodds, R. A., James, I. E., Connor, J. R., Debouck, C., Richardson, S., Lee-Rykacewski, E., Coleman, L., Rieman, D., Barthlow, R., Hastings, G., and Gowen, M. Cathepsin K, but not Cathepsins B, L or S, is abundantly expressed in human osteoclasts. J. Biol. Chem., 271: 12511-12516, 1996.
11. Johnson, M. D., Torri, J. A., Lippman, M. E., and Dickson, R. B. The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res., 53: 873-877, 1993.
12. Scaddan, P. B., and Dufresne, M. J. Characterisation of cysteine proteases and their endogenous inhibitors in MCF-7 and adriamycin-resistant MCF-7 human breast cancer cells. Invasion Metastasis, 13: 301-313, 1993.
13. Escot, C., Zhao, Y., and Rochefort, H. Cellular localization by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer. Breast Cancer Res. Treat., 38: 217-226, 1996.
14. Rochefort, H. Oestrogens, proteases and breast cancer. From cell lines to clinical applications. Eur. J. Cancer, 30A: 1583-1586, 1994.
15. Rochefort, H. Cathepsin D in breast cancer. Breast Cancer Res. Treat., 16: 3-13, 1990.
16. Tetu, B., Brisson, J., Cote, C., Brisson, S., Potuin, D., and Roberge, N. Prognostic significance of cathepsin D expression in node positive breast carcinoma: an immunohistochemical study. Int. J. Cancer, 55: 429-435, 1993.
17. Joensuu, H., Toikkanen, S., and Isola, J. Stromal cell cathepsin D expression and long term survival in breast cancer. Br. J. Cancer, 71: 155-159, 1995.
18. Bossard, M. J., Tomaszek, T. A., Thomson, S. K., Amegadzie, B. Y., Hanning, C. R., Jones, C., Kurdyla, J. T., McNulty, D. E., Drake, F. H., Gowen, M., and Levy, M. A. Proteolytic activity of human osteoclast cathepsin K. J. Biol. Chem., 271: 12517-12524, 1996.
19. Clohisy, D. R., Palkert, D., Ramnaraine, M. L., Pekurovsky, I., and Oursler, M. J. Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis. J. Orthop. Res., 14: 396-402, 1996.
20. Orr, F. W., Kostenuik, P., Sanchez-Sweatman, O. H., and Singh, G. Mechanisms involved in the metastasis of cancer to bone. Breast Cancer Res. Treat., 25: 151-163, 1993.
21. Mundy, G. R. Mechanisms of osteolytic bone destruction. Bone, 12 (Suppl. 1): S1-S6, 1991.
22. Rubens, R. D. Improving treatment for advanced breast cancer. Cancer Surv., 18: 199-209, 1993.
23. Rossi, J. F. Bone tissue and cancer. Pathol. Biol., 38: 69-79, 1990.
24. Athanasou, N. A., and Quinn, J. M. Human tumour-associated macrophages are capable of bone resorption. Br. J. Cancer, 65: 523-526, 1992.
25. Clohisy, D. R., Ogilvie, C. M., Carpenter, R. J., and Ramnaraine, M. L. Localized, tumor associated osteolysis involves the recruitment and activation of osteoclasts. J. Orthop. Res., 14: 2-6, 1996.
26. Eilon, G., and Mundy, G. R. Association of increased cyclic adenosine 3′:5′-monophosphate content in cultured human breast cancer cells and release of hydrolytic enzymes and bone-resorbing activity. Cancer Res., 43: 5792-5794, 1983.